Skip to main content

About IBC

header.jpg
The Institutional Biosafety Committee (IBC) supervises the use of recombinant DNA and handles other biological safety and hazard issues in experiments conducted at Brigham Young University at a BSL2 or 3, such as constructing and handling DNA molecules in organisms. The IBC must review and approve all proposed experiments in advance before work can begin. The IBC has jurisdiction, regardless of the funding source or instructional nature of any recombinant DNA experiments.

IBC Meeting Schedule

Meetings are held on the second Thursday in January, March, May, July, September, and November. Primary investigators must complete and submit applications by the 25th of the month prior to when they would like their protocol reviewed. For example, to be on the March agenda, protocols must be submitted by February 25th.